
Eric Haines is a biotech scientist, strategist, and operator working at the intersection of translational science, company formation, and capital strategy. With more than 15 years of experience across biotech and life sciences, he has partnered with early-stage founders to define development strategies, advance preclinical and early clinical programs, assess competitive landscapes, and position companies for successful fundraising and investor engagement.
He is currently the Founder of a biotech consulting firm and a Venture Scout at Flusso Capital, where he works closely with select founders and investors to evaluate emerging therapeutic platforms and support early company building. Eric brings a rigorous, science-driven approach combined with a pragmatic understanding of execution, helping teams align scientific innovation with clear value creation and long-term impact.